Transarterial chemoembolization in soft-tissue sarcoma metastases to the liver - The use of imaging biomarkers as predictors of patient survival

This study confirmed the role of cTACE as a safe salvage therapy option in patients with mSTS of the liver. The demonstrated advantages of enhancement-based tumor response assessment techniques over size-based criteria validate mRECIST and qEASL as preferable methods after intraarterial therapy.